Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mevastatin (Compactin) (CAS 73573-88-3)

5.0(1)
Write a reviewAsk a question

See product citations (18)

Alternate Names:
Compactin
Application:
Mevastatin (Compactin) is an HMGCR (HMG-CoA reductase) inhibitor
CAS Number:
73573-88-3
Purity:
≥97%
Molecular Weight:
390.5
Molecular Formula:
C23H34O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Mevastatin (Compactin) inhibits HMGCR (HMG-CoA reductase) (Ki for acid form is 1 nM) which in turn inhibits isoprenoid biosynthesis and therefore blocks protein isoprenylation. Mevastatin causes cells to arrest early in the G1 phase. Mevastatin is a close structural analog of lovastatin (sc-200850) and both agents have the same biochemical activities. Mevastatin is inactive in cell-free assays. In cells however, it is hydrolyzed to the active free acid form by intracellular esterases.


Mevastatin (Compactin) (CAS 73573-88-3) References

  1. Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis.  |  Izquierdo, D., et al. 2004. Fertil Steril. 82 Suppl 3: 1193-7. PMID: 15474095
  2. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation.  |  Akasaki, Y., et al. 2009. Osteoarthritis Cartilage. 17: 235-43. PMID: 18672387
  3. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR.  |  Evangelopoulos, ME., et al. 2009. J Neurosci Res. 87: 2138-44. PMID: 19224573
  4. Effects of mevastatin on grafted bone in MRL/MpJ mice.  |  Sugazaki, M., et al. 2010. Connect Tissue Res. 51: 105-12. PMID: 20109072
  5. Antileishmanial effect of mevastatin is due to interference with sterol metabolism.  |  Dinesh, N., et al. 2015. Parasitol Res. 114: 3873-83. PMID: 26183607
  6. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation.  |  Hsu, CK., et al. 2015. Br J Pharmacol. 172: 5360-76. PMID: 26359950
  7. Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells.  |  Lin, Z., et al. 2017. Oncotarget. 8: 17833-17848. PMID: 28147319
  8. Mevastatin promotes neuronal survival against Aβ-induced neurotoxicity through AMPK activation.  |  Kornelius, E., et al. 2017. Metab Brain Dis. 32: 1999-2007. PMID: 28840430
  9. Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5.  |  Sawaya, AP., et al. 2018. J Biol Chem. 293: 1439-1449. PMID: 29158265
  10. Essential role for mevalonate synthesis in DNA replication.  |  Quesney-Huneeus, V., et al. 1979. Proc Natl Acad Sci U S A. 76: 5056-60. PMID: 291922
  11. Mevastatin promotes healing by targeting caveolin-1 to restore EGFR signaling.  |  Sawaya, AP., et al. 2019. JCI Insight. 4: PMID: 31661463
  12. Mevastatin-Induced AP-1-Dependent HO-1 Expression Suppresses Vascular Cell Adhesion Molecule-1 Expression and Monocyte Adhesion on Human Pulmonary Alveolar Epithelial Cells Challenged with TNF-α.  |  Yang, CM., et al. 2020. Biomolecules. 10: PMID: 32121588
  13. The dual role of mevalonate in the cell cycle.  |  Quesney-Huneeus, V., et al. 1983. J Biol Chem. 258: 378-85. PMID: 6848509

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Mevastatin (Compactin), 10 mg

sc-200853
10 mg
$77.00

Mevastatin (Compactin), 50 mg

sc-200853A
50 mg
$179.00

What is the solubility of this product?

Asked by: hawkeye11
Thank you for your question. This chemical is soluble in DMSO at 78 mg/mL and water and ethanol at <1 mg/mL. Please contact Technical Service if you have further questions concerning this product.
Answered by: Tech Service 9
Date published: 2016-12-22
  • y_2026, m_3, d_26, h_7CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_200853, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 161ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Vukelic et alVukelic et al. (PubMed ID 19903814) found that Mevastatin (Compactin) decreased the amount of farnesyl pyrophosphate (FPP) available to bind with glucocorticoid receptor (GR) and reversed zaragozic acid A-mediated inhibitory effects, promoting epithelialization and would healing. -SCBT Publication Review
Date published: 2015-05-08
  • y_2026, m_3, d_26, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200853, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 9ms
  • REVIEWS, PRODUCT
Mevastatin (Compactin) | CAS 73573-88-3 is rated 5.0 out of 5 by 1.
  • y_2026, m_3, d_26, h_7
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_200853, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 100ms
  • REVIEWS, PRODUCT